Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the highest tolerated dose, safety and activity of
HCD122 in patients with Multiple Myeloma who are relapsed after receiving prior treatment.